1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Systemic Antifungals Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Injections
        1.2.3 Oral
    1.3 Market by Application
        1.3.1 Global Systemic Antifungals Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Drugstores
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Systemic Antifungals Market Perspective (2017-2028)
    2.2 Systemic Antifungals Growth Trends by Region
        2.2.1 Systemic Antifungals Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Systemic Antifungals Historic Market Size by Region (2017-2022)
        2.2.3 Systemic Antifungals Forecasted Market Size by Region (2023-2028)
    2.3 Systemic Antifungals Market Dynamics
        2.3.1 Systemic Antifungals Industry Trends
        2.3.2 Systemic Antifungals Market Drivers
        2.3.3 Systemic Antifungals Market Challenges
        2.3.4 Systemic Antifungals Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Systemic Antifungals Players by Revenue
        3.1.1 Global Top Systemic Antifungals Players by Revenue (2017-2022)
        3.1.2 Global Systemic Antifungals Revenue Market Share by Players (2017-2022)
    3.2 Global Systemic Antifungals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Systemic Antifungals Revenue
    3.4 Global Systemic Antifungals Market Concentration Ratio
        3.4.1 Global Systemic Antifungals Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Systemic Antifungals Revenue in 2021
    3.5 Systemic Antifungals Key Players Head office and Area Served
    3.6 Key Players Systemic Antifungals Product Solution and Service
    3.7 Date of Enter into Systemic Antifungals Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Antifungals Breakdown Data by Type
    4.1 Global Systemic Antifungals Historic Market Size by Type (2017-2022)
    4.2 Global Systemic Antifungals Forecasted Market Size by Type (2023-2028)
5 Systemic Antifungals Breakdown Data by Application
    5.1 Global Systemic Antifungals Historic Market Size by Application (2017-2022)
    5.2 Global Systemic Antifungals Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Systemic Antifungals Market Size (2017-2028)
    6.2 North America Systemic Antifungals Market Size by Country (2017-2022)
    6.3 North America Systemic Antifungals Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Systemic Antifungals Market Size (2017-2028)
    7.2 Europe Systemic Antifungals Market Size by Country (2017-2022)
    7.3 Europe Systemic Antifungals Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Systemic Antifungals Market Size (2017-2028)
    8.2 Asia-Pacific Systemic Antifungals Market Size by Country (2017-2022)
    8.3 Asia-Pacific Systemic Antifungals Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Systemic Antifungals Market Size (2017-2028)
    9.2 Latin America Systemic Antifungals Market Size by Country (2017-2022)
    9.3 Latin America Systemic Antifungals Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Systemic Antifungals Market Size (2017-2028)
    10.2 Middle East & Africa Systemic Antifungals Market Size by Country (2017-2022)
    10.3 Middle East & Africa Systemic Antifungals Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 MSD
        11.1.1 MSD Company Detail
        11.1.2 MSD Business Overview
        11.1.3 MSD Systemic Antifungals Introduction
        11.1.4 MSD Revenue in Systemic Antifungals Business (2017-2022)
        11.1.5 MSD Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Systemic Antifungals Introduction
        11.2.4 Pfizer Revenue in Systemic Antifungals Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Astellas Pharma
        11.3.1 Astellas Pharma Company Detail
        11.3.2 Astellas Pharma Business Overview
        11.3.3 Astellas Pharma Systemic Antifungals Introduction
        11.3.4 Astellas Pharma Revenue in Systemic Antifungals Business (2017-2022)
        11.3.5 Astellas Pharma Recent Development
    11.4 Gilead Sciences
        11.4.1 Gilead Sciences Company Detail
        11.4.2 Gilead Sciences Business Overview
        11.4.3 Gilead Sciences Systemic Antifungals Introduction
        11.4.4 Gilead Sciences Revenue in Systemic Antifungals Business (2017-2022)
        11.4.5 Gilead Sciences Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Systemic Antifungals Introduction
        11.5.4 Merck Revenue in Systemic Antifungals Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Detail
        11.6.2 Bayer Business Overview
        11.6.3 Bayer Systemic Antifungals Introduction
        11.6.4 Bayer Revenue in Systemic Antifungals Business (2017-2022)
        11.6.5 Bayer Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Detail
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Systemic Antifungals Introduction
        11.7.4 Novartis Revenue in Systemic Antifungals Business (2017-2022)
        11.7.5 Novartis Recent Development
    11.8 Liposome Company
        11.8.1 Liposome Company Company Detail
        11.8.2 Liposome Company Business Overview
        11.8.3 Liposome Company Systemic Antifungals Introduction
        11.8.4 Liposome Company Revenue in Systemic Antifungals Business (2017-2022)
        11.8.5 Liposome Company Recent Development
    11.9 Xian-janssen
        11.9.1 Xian-janssen Company Detail
        11.9.2 Xian-janssen Business Overview
        11.9.3 Xian-janssen Systemic Antifungals Introduction
        11.9.4 Xian-janssen Revenue in Systemic Antifungals Business (2017-2022)
        11.9.5 Xian-janssen Recent Development
    11.10 CR Pharma
        11.10.1 CR Pharma Company Detail
        11.10.2 CR Pharma Business Overview
        11.10.3 CR Pharma Systemic Antifungals Introduction
        11.10.4 CR Pharma Revenue in Systemic Antifungals Business (2017-2022)
        11.10.5 CR Pharma Recent Development
    11.11 Chiatai Tianqing
        11.11.1 Chiatai Tianqing Company Detail
        11.11.2 Chiatai Tianqing Business Overview
        11.11.3 Chiatai Tianqing Systemic Antifungals Introduction
        11.11.4 Chiatai Tianqing Revenue in Systemic Antifungals Business (2017-2022)
        11.11.5 Chiatai Tianqing Recent Development
    11.12 Haisco Pharmaceutical
        11.12.1 Haisco Pharmaceutical Company Detail
        11.12.2 Haisco Pharmaceutical Business Overview
        11.12.3 Haisco Pharmaceutical Systemic Antifungals Introduction
        11.12.4 Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022)
        11.12.5 Haisco Pharmaceutical Recent Development
    11.13 Zhuhai Ebang Pharmaceutical
        11.13.1 Zhuhai Ebang Pharmaceutical Company Detail
        11.13.2 Zhuhai Ebang Pharmaceutical Business Overview
        11.13.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Introduction
        11.13.4 Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022)
        11.13.5 Zhuhai Ebang Pharmaceutical Recent Development
    11.14 Livzon Group Livzon Pharmaceutical Factory
        11.14.1 Livzon Group Livzon Pharmaceutical Factory Company Detail
        11.14.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
        11.14.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Introduction
        11.14.4 Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2017-2022)
        11.14.5 Livzon Group Livzon Pharmaceutical Factory Recent Development
    11.15 Honz Pharmaceutical
        11.15.1 Honz Pharmaceutical Company Detail
        11.15.2 Honz Pharmaceutical Business Overview
        11.15.3 Honz Pharmaceutical Systemic Antifungals Introduction
        11.15.4 Honz Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022)
        11.15.5 Honz Pharmaceutical Recent Development
    11.16 Medisan
        11.16.1 Medisan Company Detail
        11.16.2 Medisan Business Overview
        11.16.3 Medisan Systemic Antifungals Introduction
        11.16.4 Medisan Revenue in Systemic Antifungals Business (2017-2022)
        11.16.5 Medisan Recent Development
    11.17 Chengdu Brilliant Pharmaceutical
        11.17.1 Chengdu Brilliant Pharmaceutical Company Detail
        11.17.2 Chengdu Brilliant Pharmaceutical Business Overview
        11.17.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Introduction
        11.17.4 Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022)
        11.17.5 Chengdu Brilliant Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Systemic Antifungals Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Injections
    Table 3. Key Players of Oral
    Table 4. Global Systemic Antifungals Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Systemic Antifungals Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Systemic Antifungals Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Systemic Antifungals Market Share by Region (2017-2022)
    Table 8. Global Systemic Antifungals Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Systemic Antifungals Market Share by Region (2023-2028)
    Table 10. Systemic Antifungals Market Trends
    Table 11. Systemic Antifungals Market Drivers
    Table 12. Systemic Antifungals Market Challenges
    Table 13. Systemic Antifungals Market Restraints
    Table 14. Global Systemic Antifungals Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Systemic Antifungals Market Share by Players (2017-2022)
    Table 16. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2021)
    Table 17. Ranking of Global Top Systemic Antifungals Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Systemic Antifungals Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Systemic Antifungals Product Solution and Service
    Table 21. Date of Enter into Systemic Antifungals Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Systemic Antifungals Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Systemic Antifungals Revenue Market Share by Type (2017-2022)
    Table 25. Global Systemic Antifungals Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Systemic Antifungals Revenue Market Share by Type (2023-2028)
    Table 27. Global Systemic Antifungals Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Systemic Antifungals Revenue Market Share by Application (2017-2022)
    Table 29. Global Systemic Antifungals Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Systemic Antifungals Revenue Market Share by Application (2023-2028)
    Table 31. North America Systemic Antifungals Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Systemic Antifungals Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Systemic Antifungals Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Systemic Antifungals Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Systemic Antifungals Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Systemic Antifungals Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Systemic Antifungals Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Systemic Antifungals Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Systemic Antifungals Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Systemic Antifungals Market Size by Country (2023-2028) & (US$ Million)
    Table 41. MSD Company Detail
    Table 42. MSD Business Overview
    Table 43. MSD Systemic Antifungals Product
    Table 44. MSD Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 45. MSD Recent Development
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Systemic Antifungals Product
    Table 49. Pfizer Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. Astellas Pharma Company Detail
    Table 52. Astellas Pharma Business Overview
    Table 53. Astellas Pharma Systemic Antifungals Product
    Table 54. Astellas Pharma Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 55. Astellas Pharma Recent Development
    Table 56. Gilead Sciences Company Detail
    Table 57. Gilead Sciences Business Overview
    Table 58. Gilead Sciences Systemic Antifungals Product
    Table 59. Gilead Sciences Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 60. Gilead Sciences Recent Development
    Table 61. Merck Company Detail
    Table 62. Merck Business Overview
    Table 63. Merck Systemic Antifungals Product
    Table 64. Merck Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 65. Merck Recent Development
    Table 66. Bayer Company Detail
    Table 67. Bayer Business Overview
    Table 68. Bayer Systemic Antifungals Product
    Table 69. Bayer Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 70. Bayer Recent Development
    Table 71. Novartis Company Detail
    Table 72. Novartis Business Overview
    Table 73. Novartis Systemic Antifungals Product
    Table 74. Novartis Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Development
    Table 76. Liposome Company Company Detail
    Table 77. Liposome Company Business Overview
    Table 78. Liposome Company Systemic Antifungals Product
    Table 79. Liposome Company Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 80. Liposome Company Recent Development
    Table 81. Xian-janssen Company Detail
    Table 82. Xian-janssen Business Overview
    Table 83. Xian-janssen Systemic Antifungals Product
    Table 84. Xian-janssen Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 85. Xian-janssen Recent Development
    Table 86. CR Pharma Company Detail
    Table 87. CR Pharma Business Overview
    Table 88. CR Pharma Systemic Antifungals Product
    Table 89. CR Pharma Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 90. CR Pharma Recent Development
    Table 91. Chiatai Tianqing Company Detail
    Table 92. Chiatai Tianqing Business Overview
    Table 93. Chiatai Tianqing Systemic AntifungalsProduct
    Table 94. Chiatai Tianqing Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 95. Chiatai Tianqing Recent Development
    Table 96. Haisco Pharmaceutical Company Detail
    Table 97. Haisco Pharmaceutical Business Overview
    Table 98. Haisco Pharmaceutical Systemic AntifungalsProduct
    Table 99. Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 100. Haisco Pharmaceutical Recent Development
    Table 101. Zhuhai Ebang Pharmaceutical Company Detail
    Table 102. Zhuhai Ebang Pharmaceutical Business Overview
    Table 103. Zhuhai Ebang Pharmaceutical Systemic AntifungalsProduct
    Table 104. Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 105. Zhuhai Ebang Pharmaceutical Recent Development
    Table 106. Livzon Group Livzon Pharmaceutical Factory Company Detail
    Table 107. Livzon Group Livzon Pharmaceutical Factory Business Overview
    Table 108. Livzon Group Livzon Pharmaceutical Factory Systemic AntifungalsProduct
    Table 109. Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 110. Livzon Group Livzon Pharmaceutical Factory Recent Development
    Table 111. Honz Pharmaceutical Company Detail
    Table 112. Honz Pharmaceutical Business Overview
    Table 113. Honz Pharmaceutical Systemic AntifungalsProduct
    Table 114. Honz Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 115. Honz Pharmaceutical Recent Development
    Table 116. Medisan Company Detail
    Table 117. Medisan Business Overview
    Table 118. Medisan Systemic AntifungalsProduct
    Table 119. Medisan Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 120. Medisan Recent Development
    Table 121. Chengdu Brilliant Pharmaceutical Company Detail
    Table 122. Chengdu Brilliant Pharmaceutical Business Overview
    Table 123. Chengdu Brilliant Pharmaceutical Systemic AntifungalsProduct
    Table 124. Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2017-2022) & (US$ Million)
    Table 125. Chengdu Brilliant Pharmaceutical Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Systemic Antifungals Market Share by Type: 2021 VS 2028
    Figure 2. Injections Features
    Figure 3. Oral Features
    Figure 4. Global Systemic Antifungals Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Drugstores Case Studies
    Figure 8. Others Case Studies
    Figure 9. Systemic Antifungals Report Years Considered
    Figure 10. Global Systemic Antifungals Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Systemic Antifungals Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Systemic Antifungals Market Share by Region: 2021 VS 2028
    Figure 13. Global Systemic Antifungals Market Share by Players in 2021
    Figure 14. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Systemic Antifungals Revenue in 2021
    Figure 16. North America Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Systemic Antifungals Market Share by Country (2017-2028)
    Figure 18. United States Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Systemic Antifungals Market Share by Country (2017-2028)
    Figure 22. Germany Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Systemic Antifungals Market Share by Region (2017-2028)
    Figure 30. China Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Systemic Antifungals Market Share by Country (2017-2028)
    Figure 38. Mexico Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Systemic Antifungals Market Share by Country (2017-2028)
    Figure 42. Turkey Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Systemic Antifungals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. MSD Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 45. Pfizer Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 46. Astellas Pharma Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 47. Gilead Sciences Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 49. Bayer Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 51. Liposome Company Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 52. Xian-janssen Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 53. CR Pharma Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 54. Chiatai Tianqing Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 55. Haisco Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 56. Zhuhai Ebang Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 57. Livzon Group Livzon Pharmaceutical Factory Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 58. Honz Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 59. Medisan Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 60. Chengdu Brilliant Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed